Overview

Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, tolerability, and safety of rasagiline compared to placebo in PD patients with motor fluctuations on levodopa therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Chongqing Fortune Pharmaceutical Co., Ltd.
Collaborator:
Beijing Bionovo Medicine Development Co., Ltd.
Treatments:
Levodopa
Rasagiline